Stafiba: A STAT5‐Selective Small‐Molecule Inhibitor

por Eckhardt, Katrin S., Münzel, Theresa, Gräb, Julian, Berg, Thorsten
Publicado 2022

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the Eur...

por Novak, Urban, Fehr, Martin, Schär, Sämi, Dreyling, Martin, Schmidt, Christian, Derenzini, Enrico, Zander, Thilo, Hess, Georg, Mey, Ulrich, Ferrero, Simone, Mach, Nicolas, Boccomini, Carola, Böttcher, Sebastian, Voegeli, Michèle, Cairoli, Anne, Ivanova, Vanesa-Sindi, Menter, Thomas, Dirnhofer, Stefan, Scheibe, Bernhard, Gadient, Sandra, Eckhardt, Katrin, Zucca, Emanuele, Driessen, Christoph, Renner, Christoph
Publicado 2023

SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma

por Stathis, Anastasios, Mey, Ulrich, Schär, Sämi, Hitz, Felicitas, Pott, Christiane, Mach, Nicolas, Krasniqi, Fatime, Novak, Urban, Schmidt, Christian, Hohloch, Karin, Kienle, Dirk Lars, Hess, Dagmar, Moccia, Alden A., Unterhalt, Michael, Eckhardt, Katrin, Hayoz, Stefanie, Forestieri, Gabriela, Rossi, Davide, Dirnhofer, Stefan, Ceriani, Luca, Sartori, Giulio, Bertoni, Francesco, Buske, Christian, Zucca, Emanuele, Hiddemann, Wolfgang
Publicado 2022